<?xml version="1.0" encoding="UTF-8"?>
<p>Atherosclerosis is characterized by the accumulation of thrombus, cells or lipids plaques within the arterial intima [
 <xref rid="B72-plants-09-01765" ref-type="bibr">72</xref>]. The activation of vascular smooth muscle cells (VSMC) is a major contributor to atherosclerosis and generates ROS. Increased ROS promotes acute inflammatory responses and subsequent vasculature dysfunction in atherosclerotic lesions [
 <xref rid="B73-plants-09-01765" ref-type="bibr">73</xref>]. Therefore, inhibiting or blocking the activation or proliferation of VSMC has proven to be a rational approach in the treatment of atherosclerosis [
 <xref rid="B74-plants-09-01765" ref-type="bibr">74</xref>].
</p>
